X0707 D LIVE 0001358403 BELLICUM PHARMACEUTICALS, INC 2130 West Holcombe Boulevard Suite 850 HOUSTON TX TEXAS 77030 (832) 384-1100 DELAWARE BELLICUM PHARMACEUTICALS INC Corporation true Thomas J. Farrell 2130 West Holcombe Boulevard Suite 850 Houston TX TEXAS 77030 Executive Officer Director Kevin M. Slawin 2130 West Holcombe Boulevard Suite 850 Houston TX TEXAS 77030 Director Frank McGuyer 2130 West Holcombe Boulevard Suite 850 Houston TX TEXAS 77030 Director James F. Brown 2130 West Holcombe Boulevard Suite 850 Houston TX TEXAS 77030 Director David M. Spencer 2130 West Holcombe Boulevard Suite 850 Houston TX TEXAS 77030 Executive Officer Dennis K. Stone 2130 West Holcombe Boulevard Suite 850 Houston TX TEXAS 77030 Director Annemarie Moseley 2130 West Holcombe Boulevard Suite 850 Houston TX TEXAS 77030 Executive Officer Ken Moseley 2130 West Holcombe Boulevard Suite 850 Houston TX TEXAS 77030 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2014-08-22 false true true true false 0 Jefferies LLC 2347 None None 520 Madison Avenue, 2nd Floor New York NY NEW YORK 10022 CA CALIFORNIA CO COLORADO MD MARYLAND MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK false 94357588 94357588 0 The Total Offering Amount and Total Amount Sold includes $39,357,588 that may be received by the Issuer upon exercise of the warrants. false 76 3141250 0 0 false BELLICUM PHARMACEUTICALS, INC /s/ Thomas J. Farrell Thomas J. Farrell President & CEO 2014-09-02